NICE has developed a medtech innovation briefing (MIB) on the Somatom Definition Edge CT scanner for imaging coronary artery disease in adults in whom imaging is difficult.

The Somatom Definition Edge is a CT scanner that can be used for computed tomography coronary angiography (CTCA), to diagnose or evaluate coronary artery disease non-invasively in people with conditions that make it difficult to obtain good-quality CTCA images. The Somatom Definition Edge has technical features that are recognised to address clinical challenges in patients who have coronary artery disease that is difficult to image, but there is no published evidence on the safety or effectiveness for this indication. It can also be used for other clinical imaging applications in adults and children. The Somatom Definition Edge typically costs about £600,000 excluding VAT, depending on the configuration.

During the review process for diagnostics guidance on new generation cardiac CT scanners, NICE became aware of the Aquilion PRIME CT scanner, which has similar technical specifications to those recommended in the guidance. NICE has also published a medtech innovation briefing on the Aquilion PRIME CT scanner.

MIBs provide a description of the medical technology, including its likely place in therapy, the costs of using the technology and a critical review of the strengths and weaknesses of the relevant published evidence.

Their purpose is to provide objective information on device and diagnostic technologies to aid local decision-making by clinicians, managers and procurement professionals. By making this information available, NICE helps to avoid the need for NHS organisations to produce similar information for local use.

MIBs are not NICE guidance. They differ in format, contain no judgement on the value of the technology and do not constitute a guidance recommendation.

MIBs are commissioned by NHS England and produced in support of the NHS 5 Year Forward View, specifically as one of a number of steps which will accelerate innovation in new treatments and diagnostics